Invention Grant
- Patent Title: Efficient method for reprogramming blood to induced pluripotent stem cells
-
Application No.: US16310360Application Date: 2017-06-16
-
Publication No.: US11572545B2Publication Date: 2023-02-07
- Inventor: Dhruv Sareen , Loren A. Ornelas , Clive Svendsen
- Applicant: CEDARS-SINAI MEDICAL CENTER
- Applicant Address: US CA Los Angeles
- Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee: CEDARS-SINAI MEDICAL CENTER
- Current Assignee Address: US CA Los Angeles
- Agency: Nixon Peabody LLP
- International Application: PCT/US2017/038041 WO 20170616
- International Announcement: WO2017/219000 WO 20171221
- Main IPC: C12N5/074
- IPC: C12N5/074 ; C12N5/00

Abstract:
Described herein are methods and compositions related to generation of induced pluripotent stem cells (iPSCs). Improved techniques for establishing highly efficient, reproducible reprogramming using non-integrating episomal plasmid vectors. Using the described reprogramming protocol, one is able to consistently reprogram non-T cells with close to 100% success from non-T cell or non-B cell sources. Further advantages include use of a defined reprogramming media E7 and using defined clinically compatible substrate recombinant human L-521. Generation of iPSCs from these blood cell sources allows for recapitulation of the entire genomic repertoire, preservation of genomic fidelity and enhanced genomic stability.
Public/Granted literature
- US20190194624A1 NOVEL AND EFFICIENT METHOD FOR REPROGRAMMING BLOOD TO INDUCED PLURIPOTENT STEM CELLS Public/Granted day:2019-06-27
Information query